Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | XBP1 | P17861 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.33 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.33 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24938786 | 0.76 | KDM4E (0.36) | KDM4EALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL19201115 | 0.73 | KDR (0.44) | KDM4EALDH1A1CLK4MAP2K1DYRK1B | |
| SCHEMBL14264667 | 0.72 | KDM4E (0.36) | KDM4EALDH1A1NPC1RAB9ANPSR1 | |
| SCHEMBL4794157 | 0.65 | KDM4E (0.61) | KDM4EALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL13990623 | 0.63 | NPC1 (0.54) | KDM4EALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL3285821 | 0.59 | KDM4E (0.39) | KDM4EALDH1A1NPC1MAPTXBP1 | |
| SCHEMBL1333523 | 0.58 | ALDH1A1 (0.49) | KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL30786518 | 0.58 | PDE10A (0.34) | — | |
| SCHEMBL3087121 | 0.57 | ALDH1A1 (0.39) | KDM4EALDH1A1NPC1MAPTXBP1 | |
| SCHEMBL13263629 | 0.57 | KDM4E (0.37) | KDM4EALDH1A1NPC1MAPTXBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020010966-A1 | OXIDATION DYEING COMPOSITION FOR KERATIN FIBRES AND DYEING METHOD USING SAID COMPOSITION | L'OREAL S.A. (FR) | 2002-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010966-A1 | OXIDATION DYEING COMPOSITION FOR KERATIN FIBRES AND DYEING METHOD USING SAID COMPOSITION | KRT18, QDPR, CYB5R3 | KDM4E 853/4885ALDH1A1 292/4885NPC1 4820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.